{
  "ptid_time": "022_S_1097_2008-12-09",
  "img_path": "/data/qiuhui/data/adni/images/022_S_1097/2008-12-09/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 33,389 mm³, 13.3% below the reference mean. With a Z-score of -0.32 (37.5th percentile), this represents normal volume ; hippocampal volume measures 5,104 mm³, 32.5% below the reference mean. With a Z-score of -3.17 (0.1th percentile), this represents profound atrophy; whole brain volume measures 946,427 mm³, 12.3% below the reference mean. With a Z-score of -1.60 (5.5th percentile), this represents moderate atrophy; entorhinal cortex volume measures 3,111 mm³, 24.1% below the reference mean. With a Z-score of -1.64 (5.1th percentile), this represents moderate atrophy; fusiform gyrus volume measures 16,304 mm³, 13.5% below the reference mean. With a Z-score of -1.15 (12.6th percentile), this represents mild atrophy; middle temporal gyrus volume measures 17,308 mm³, 18.9% below the reference mean. With a Z-score of -1.70 (4.5th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 75.0 years. Gender is Male. Education: 18 years. MMSE: 24.0. Logical Memory: 0.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 653.90 pg/mL (normal ); Total tau: 448.90 pg/mL (significant elevated); Phosphorylated tau: 46.00 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume shows profound atrophy (Z-score -3.17, 0.1th percentile), which is strongly associated with Alzheimer's disease (AD). Elevated T-tau and P-tau levels further support neurodegeneration and AD pathology, despite normal Aβ levels (atypical but possible in non-amyloid AD variants). The MMSE score of 24 suggests cognitive impairment but not severe dementia.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to underlying AD pathology given biomarker and structural findings).  \n**Confidence:** **Medium** (elevated tau and hippocampal atrophy strongly suggest AD, but normal Aβ and lack of severe functional decline keep this in MCI range).  \n\n*Note: Non-amyloid (tau-first) AD or primary age-related tauopathy (PART) could explain this profile, warranting further clinical correlation.*",
  "timestamp": "2025-07-26T02:08:55.411899"
}